Glycom A/S   Report issue

For profit Phase 2
Founded: Horsholm Denmark (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2014
NCT01927900
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Glycom, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

glucose (2 trials)

human milk oligosaccharides (3 trials)

Drugs in Other Trials (1)

fuco-n-tetraose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Irritable Bowel Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 3